MED
Income statement / Annual
Last year (2023), Medifast, Inc.'s total revenue was $1.07 B,
a decrease of 32.94% from the previous year.
In 2023, Medifast, Inc.'s net income was $99.42 M.
See Medifast, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.07 B
|
$1.60 B
|
$1.53 B
|
$934.84 M
|
$713.67 M
|
$501.00 M
|
$301.56 M
|
$274.53 M
|
$272.77 M
|
$285.29 M
|
| Cost of Revenue |
$296.20 M |
$458.16 M |
$398.49 M |
$237.03 M |
$176.81 M |
$121.10 M |
$73.75 M |
$68.87 M |
$71.46 M |
$76.08 M |
| Gross Profit |
$775.85 M |
$1.14 B |
$1.13 B |
$697.82 M |
$536.86 M |
$379.90 M |
$227.81 M |
$205.66 M |
$201.32 M |
$209.21 M |
| Gross Profit Ratio |
0.72 |
0.71 |
0.74 |
0.75 |
0.75 |
0.76 |
0.76 |
0.75 |
0.74 |
0.73 |
| Research and Development
Expenses |
$4.60 M
|
$4.50 M
|
$4.40 M
|
$2.80 M
|
$2.70 M
|
$2.20 M
|
$1.50 M
|
$2.00 M
|
$1.80 M
|
$1.30 M
|
| General & Administrative
Expenses |
$646.05 M
|
$953.91 M
|
$909.76 M
|
$559.26 M
|
$440.52 M
|
$304.84 M
|
$0.00
|
$169.41 M
|
$157.33 M
|
$161.96 M
|
| Selling & Marketing
Expenses |
$3.40 M
|
$1.70 M
|
$1.60 M
|
$4.40 M
|
$5.30 M
|
$6.00 M
|
$0.00
|
$9.40 M
|
$15.30 M
|
$17.00 M
|
| Selling, General &
Administrative Expenses |
$649.45 M
|
$955.61 M
|
$911.36 M
|
$563.66 M
|
$445.82 M
|
$310.84 M
|
$188.18 M
|
$178.81 M
|
$172.63 M
|
$178.96 M
|
| Other Expenses |
$0.00 |
-$46,000.00 |
$119,000.00 |
-$140,000.00 |
$29,000.00 |
$179,000.00 |
$136,000.00 |
-$20,000.00 |
$326,000.00 |
$731,000.00 |
| Operating Expenses |
$649.45 M |
$955.61 M |
$911.36 M |
$563.66 M |
$445.82 M |
$310.84 M |
$188.18 M |
$178.81 M |
$172.63 M |
$178.96 M |
| Cost And Expenses |
$945.65 M |
$1.41 B |
$1.31 B |
$800.68 M |
$622.63 M |
$431.94 M |
$261.93 M |
$247.68 M |
$244.09 M |
$255.04 M |
| Interest Income |
$2.49 M |
$701,000.00 |
$231,000.00 |
$246,000.00 |
$1.30 M |
$1.31 M |
$558,000.00 |
$283,000.00 |
$661,000.00 |
$716,000.00 |
| Interest Expense |
$0.00 |
$701,000.00 |
$231,000.00 |
$0.00 |
$0.00 |
$1.31 M |
$558,000.00 |
$283,000.00 |
$661,000.00 |
$716,000.00 |
| Depreciation &
Amortization |
$13.11 M
|
$17.08 M
|
$11.88 M
|
$7.27 M
|
$4.62 M
|
$4.44 M
|
$4.21 M
|
$5.41 M
|
$7.12 M
|
$8.05 M
|
| EBITDA |
$139.51 M
|
$201.84 M
|
$223.05 M
|
$134.16 M
|
$95.66 M
|
$73.50 M
|
$43.84 M
|
$32.26 M
|
$37.88 M
|
$38.30 M
|
| EBITDA Ratio |
0.13 |
0.12 |
0.15 |
0.14 |
0.13 |
0.14 |
0.13 |
0.1 |
0.11 |
0.11 |
| Operating Income Ratio
|
0.12
|
0.12
|
0.14
|
0.14
|
0.13
|
0.14
|
0.13
|
0.1
|
0.11
|
0.11
|
| Total Other
Income/Expenses Net |
$2.40 M
|
-$747,000.00
|
-$112,000.00
|
$106,001.00
|
$1.32 M
|
$1.49 M
|
$694,000.00
|
$263,000.00
|
$987,000.00
|
$1.45 M
|
| Income Before Tax |
$128.80 M |
$184.06 M |
$216.13 M |
$134.27 M |
$92.36 M |
$70.55 M |
$40.33 M |
$27.12 M |
$29.67 M |
$31.69 M |
| Income Before Tax Ratio
|
0.12
|
0.12
|
0.14
|
0.14
|
0.13
|
0.14
|
0.13
|
0.1
|
0.11
|
0.11
|
| Income Tax Expense |
$29.38 M |
$40.49 M |
$52.10 M |
$31.41 M |
$14.45 M |
$14.76 M |
$12.61 M |
$9.29 M |
$10.10 M |
$10.66 M |
| Net Income |
$99.42 M |
$143.57 M |
$164.03 M |
$102.86 M |
$77.92 M |
$55.79 M |
$27.72 M |
$17.84 M |
$20.06 M |
$13.18 M |
| Net Income Ratio |
0.09 |
0.09 |
0.11 |
0.11 |
0.11 |
0.11 |
0.09 |
0.06 |
0.07 |
0.05 |
| EPS |
9.13 |
12.82 |
14.01 |
8.74 |
6.62 |
4.67 |
2.32 |
1.51 |
1.68 |
1.04 |
| EPS Diluted |
9.1 |
12.73 |
13.89 |
8.68 |
6.43 |
4.62 |
2.29 |
1.49 |
1.66 |
1.03 |
| Weighted Average Shares
Out |
$10.88 M
|
$11.20 M
|
$11.71 M
|
$11.77 M
|
$11.77 M
|
$11.95 M
|
$11.92 M
|
$11.84 M
|
$11.96 M
|
$12.67 M
|
| Weighted Average Shares
Out Diluted |
$10.92 M
|
$11.28 M
|
$11.81 M
|
$11.85 M
|
$12.12 M
|
$12.08 M
|
$12.09 M
|
$11.95 M
|
$12.07 M
|
$12.78 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
